Open AccessPALBOCICLIB IN COMBINATION WITH HORMONE THERAPY FOR LUMINAL HER2-NEGATIVE METASTATIC BREAST CANCER: NEW HIGHLY EFFECTIVE STRATEGY OF DRUG TREATMENT
Author(s) -
Е. В. Артамонова
Publication year - 2017
Publication title -
opuholi ženskoj reproduktivnoj sistemy
Language(s) - English
Resource type - Journals
eISSN - 1999-8627
pISSN - 1994-4098
DOI - 10.17650/1994-4098-2017-13-3-28-40
Subject(s) - palbociclib , fulvestrant , medicine , metastatic breast cancer , tolerability , letrozole , oncology , breast cancer , neutropenia , clinical trial , combination therapy , hormone therapy , cancer , adverse effect , estrogen receptor , chemotherapy , tamoxifen